Oppenheimer Asset Management Inc. Boosts Stake in Agilent Technologies, Inc. $A

Oppenheimer Asset Management Inc. boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 75.9% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 96,824 shares of the medical research company’s stock after purchasing an additional 41,794 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Agilent Technologies were worth $12,861,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in A. State Street Corp boosted its position in shares of Agilent Technologies by 1.9% during the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after buying an additional 241,029 shares during the period. Geode Capital Management LLC lifted its stake in Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after acquiring an additional 25,139 shares in the last quarter. Morgan Stanley boosted its holdings in Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after acquiring an additional 692,202 shares during the period. Norges Bank acquired a new position in Agilent Technologies in the 4th quarter valued at about $549,158,000. Finally, Cantillon Capital Management LLC increased its stake in Agilent Technologies by 0.8% during the fourth quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock worth $423,945,000 after purchasing an additional 23,493 shares during the period. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Agilent Technologies Price Performance

Shares of A opened at $148.55 on Friday. The firm has a market capitalization of $41.96 billion, a price-to-earnings ratio of 29.83, a PEG ratio of 2.64 and a beta of 1.25. The firm’s fifty day simple moving average is $135.38 and its 200-day simple moving average is $125.56. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were given a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on A. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. Morgan Stanley boosted their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday. TD Cowen increased their price objective on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Piper Sandler assumed coverage on Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price for the company. Finally, Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.